Prestudy: Lifestyle and Cardiovascular Disease
2 other identifiers
interventional
5
1 country
1
Brief Summary
The purpose of this pilot study is to optimize conditions for a planned human intervention study focusing on how diet predispose for, and influence, lifestyle disease development and its consequence in cardiovascular disease development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Mar 2006
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 2, 2008
CompletedFirst Posted
Study publicly available on registry
January 14, 2008
CompletedJanuary 30, 2017
January 1, 2017
1 month
January 2, 2008
January 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in microarray gene expression profiles in blood and subcutaneous abdominal fat tissue from healthy obese men, as a consequence of changes in dietary macro nutrient composition.
Four weeks
Secondary Outcomes (1)
Time to stabilization of gene expression changes due to dietary intervention.
0, 1, 2, 7, 14 and 28 days
Study Arms (1)
1
EXPERIMENTALAll participants underwent the same dietary intervention
Interventions
Isocaloric dietary changes from typically Western diet to balanced macronutrient composition.
Eligibility Criteria
You may qualify if:
- healthy males, BMI\>30
You may not qualify if:
- known chronic disease or in need of any medical treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
- FUGE Mid-Norwaycollaborator
Study Sites (1)
Norwegian University of Science and Technology
Trondheim, Mid-Norway, 7491, Norway
Related Publications (1)
Brattbakk HR, Arbo I, Aagaard S, Lindseth I, de Soysa AK, Langaas M, Kulseng B, Lindberg F, Johansen B. Balanced caloric macronutrient composition downregulates immunological gene expression in human blood cells-adipose tissue diverges. OMICS. 2013 Jan;17(1):41-52. doi: 10.1089/omi.2010.0124. Epub 2011 Jun 16.
PMID: 21679058RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Berit Johansen, PhD
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2008
First Posted
January 14, 2008
Study Start
March 1, 2006
Primary Completion
April 1, 2006
Study Completion
April 1, 2006
Last Updated
January 30, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share